Answers are grounded in this paper and cite their sources.
Worldwide, countries are examining whether to implement 1-dose human papillomavirus (HPV) vaccination instead of using 2 doses. To inform policy, we sought to project the population-level impact and efficiency of switching from 2-dose to 1-dose gender-neutral routine HPV vaccination in Canada.
No takes yet. Share an insight, caveat, or question.
Drolet et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: